Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TOPAS simulation of photoneutrons in radiotherapy: accuracy and speed with variance reduction.

Physics in medicine and biology·2024
Same author

Spatiotemporal optimisation of prostate intensity modulated proton therapy (IMPT) treatments.

Physics in medicine and biology·2022
Same author

TOPAS-nBio validation for simulating water radiolysis and DNA damage under low-LET irradiation.

Physics in medicine and biology·2021
Same author

TOPAS-nBio: An Extension to the TOPAS Simulation Toolkit for Cellular and Sub-cellular Radiobiology.

Radiation research·2019
Same author

Online adaption approaches for intensity modulated proton therapy for head and neck patients based on cone beam CTs and Monte Carlo simulations.

Physics in medicine and biology·2018
Same author

A New Standard DNA Damage (SDD) Data Format.

Radiation research·2018
Same journal

Effective contrast-enhanced preprocessing for intracranial artery segmentation in digital subtraction angiography.

Physics in medicine and biology·2026
Same journal

Improving Plan Quality in Adaptive Proton Therapy Using an Interactive Dose Modification Tool.

Physics in medicine and biology·2026
Same journal

Technical Note: Real-Time MLC Control and Latency Measurement Optimization with External Verification.

Physics in medicine and biology·2026
Same journal

Fetus-Specific Hematopoietic Stem Cell Dosimetry Framework for Leukemia-Relevant Target Cells During Prenatal Development.

Physics in medicine and biology·2026
Same journal

Deep learning-based dose prediction to enhance planning efficiency in cervical brachytherapy with hybrid applicators.

Physics in medicine and biology·2026
Same journal

Corrigendum: Referenceless MR thermometry-a comparison of five methods (2017<i>Phys. Med. Biol</i>.<b>62</b>1-16).

Physics in medicine and biology·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Elevated LET components in clinical proton beams.

C Grassberger1, H Paganetti

  • 1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. cgrassberger@partners.org

Physics in Medicine and Biology
|October 4, 2011
PubMed
Summary
This summary is machine-generated.

Secondary protons significantly increase dose-averaged linear energy transfer (LET(d)) in proton therapy, impacting biological treatment planning. Understanding these secondary particles is crucial for accurate radiobiological effectiveness calculations.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Experiment Videos

Last Updated: May 28, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Physics

Background:

  • Proton therapy utilizes proton beams for cancer treatment.
  • Accurate dose and linear energy transfer (LET) calculations are vital for effective biological treatment planning.
  • Secondary particles generated during proton interactions can influence dose distribution and biological effects.

Purpose of the Study:

  • To quantify the contribution of secondary particles, particularly secondary protons and recoils, to the dose-averaged LET (LET(d)) in proton beams.
  • To assess the impact of these secondary particles on biological treatment planning and radiobiological effectiveness.
  • To investigate the influence of beam delivery techniques (passive scattering vs. active scanning) and phantom inhomogeneities on LET distributions.

Main Methods:

  • Proton Monte Carlo simulations were performed in water phantoms and patient-specific models.
  • Simulations accounted for primary protons, secondary particles (including secondary protons and nuclear recoils), and inelastic nuclear interactions.
  • Dose-averaged LET (LET(d)) was calculated and compared with and without the inclusion of secondary particles.

Main Results:

  • Secondary protons were found to have LET(d) values up to 10 times higher than primary protons at the same depth.
  • The inclusion of secondary protons increased LET(d) by approximately 50% along the central axis and over 200% in the penumbra.
  • The maximum LET(d) after the Bragg peak increased from 12 to 15 keV µm⁻¹ with secondary protons.
  • Recoil nuclei (A > 3) contributed minimally (1.2%) to the dose in the entrance region for a prostate case, though their biological impact requires further study.

Conclusions:

  • Secondary protons play a significant role in determining LET(d) in proton therapy, necessitating their inclusion in biological treatment planning.
  • Accurate modeling of LET(d) requires consideration of secondary particle production, especially for analytical methods.
  • Findings highlight the importance of secondary particles for LET-based radiobiological effectiveness calculations and analysis of radiobiological experiments.
  • Inhomogeneities and beam delivery methods (passive vs. active scanning) subtly alter LET distributions, underscoring the complexity of proton beam modeling.